Cardiovascular Research

Article	Citations
Corrigendum to: Scientist on the spot: Exploring the cause and cure for pulmonary arterial hypertension	1360
Cardioprotective effects of Empagliflozin in cardiac volume overload-induced by aortocaval fistula in rats	186
Murine matrix metalloproteinase 13 and human matrix metalloproteinase 1 are involved in remodelling processes after myocardial infarction	183
Timing of capillary enlargement after adenoviral VEGF gene transfer does not support post-ischemic skeletal muscle recovery in hyperlipidemic mice	161
In vivo calcium and voltage mapping of the zebrafish heart	155
Early biomarkers of disease in hypertrophic cardiomyopathy: does telomere length matter?	125
Caveolin-dependent endocytosis regulates arterial calcification	112
The endocannabinoid ARA-S acts as an endogenous rescuing factor of Kv7.1/KCNE1 carrying Long QT syndrome mutations and paves the way for drug development strategies	108
The mechanistic role of connexin 43 in maturation of hiPSC cardiomyocytes	107
Role of NOD1 in atrial myopathy associated with heart failure	101
The role of natural anti-oxidants in gut microbiota alteration subsequent to high fat diet (HFD)	101
Stage specific effects of insulin and Wnt on cell fate decisions in human induced pluripotent stem cell-derived cardiomyocytes	94
From genes to phenotype: investigating the link between smad2rs29725537:c>a and high take off in mice	93
Transcriptional regulation of macrophage inflammation in the heart failure with preserved ejection fraction	90
FABP4 as potential indicator for GDM-induced fetal endothelial dysfunction	89
Impaired autophagy mechanisms associated with phospholamban-R14del disease	89
The role of FGL2 in vascular smooth muscle cell dysfunction in coronary artery bypass vein graft failure	88
Single-cell RNA sequencing analysis of the human fetal epicardium reveals several new genes involved in regulation of epicardial activation	87
Lenti-viral overexpression of RhoGEF Trio reduces CD8 T cell extravasation into atherosclerotic vein graft lesions in mice	82
Deficiency of Abca1 and Abcg1 mediated cholesterol efflux pathways in smooth muscle cells enhances vasoconstriction but does not affect atherosclerosis	81
Mechanisms of vascular inflammaging: TNF-alpha mediates endothelial CEACAM1 expression by NF-KB and beta-Catenin in a biphasic manner	79
Differential preoperative transcriptomic profiles are related to the quality of left ventricle reverse remodelling one year after valve replacement in patients with severe aortic valve stenosis	78
Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis	76
Cardiovascular toxicity profile of doxorubicin: data mining of the FDA adverse event reporting system (FAERS)	73
Asporin expression is associated with human atherosclerotic plaque integrity	72

Rapamycin reduces atherosclerotic plaque inflammation in aged mice	72
Circulating cluster miR-99b/let-7e/miR-125a expression associates with endothelial function, cytokine, and chemokine levels in myocardial infarction patients	71
Inflammasome activation dynamics within the first 24 hours in patients treated with PCI for myocardial infarction is influenced by the age of patients, preliminary report	69
The aging of neutrophils is actively involved in the cardio-metabolic consequences of high fat diet	67
Drug-interacting gene expression levels differ between atherosclerotic plaque subtypes	67
Short- and long term preservation of cardiac tissue-engineered constructs	63
Modulating sialylation as therapeutic approach for preventing age-associated cardiac dysfunction	62
Elderberry extract inhibits tumour necrosis factor induced monocyte adhesion to endothelial cells via modulation of the NF-κB pathway	60
Tenascin-C provokes cardiac fibrosis and endothelial impairment in Duchenne Muscular Dystrophy	59
Corrigendum to: Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines	58
Cardiomyocyte-derived fibrosis as driver of cardiomyopathy	58
Scientists on the spot: Costantino Iadecola	55
Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart	55
Cardioprotection in cardio-oncology: a case for concern?	53
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction	53
Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment	53
Clinical Case 17—A catastrophic case of ischemic stroke and acute myocarditis in a young patient following mRNA COVID-19 vaccination: coincidence or consequence?	52
Expression of Concern	51
p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning	51
Editor’s Note: RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries [Cardiovasc Res 2007;73:190-197]	51
Retracted: Clinical Case 28—Hyperacute synchronous cardiocerebral infarction in a patient with new-onset atrial fibrillation a rare case of MINOCA	50
Inflammation-induced arterial dysfunction in atherosclerosis; the modulating action of mesenchymal stem cell-derived extracellular vesicles	50
Retracted: Poster No. 030 Young patient with hyperhomocysteinemia and multiple atherosclerotic vascular lesions	50
Modulation of amygdala and hippocampus during anxiety by heart and middle frontal gyrus	50
Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction	49
Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators	49
Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans	49
GDF15 antagonism limits severe heart failure and prevents cardiac cachexia	49
Mast cells: a novel therapeutic avenue for cardiovascular diseases?	48
A proteomic atlas of atherosclerosis: regional proteomic signatures for plaque inflammation and calcification	47
Long-term impact of postnatal overfeeding on cardio-metabolism risk and on sensitivity to ischemia-reperfusion injury in vivo	47
Beyond the prothrombotic transcript of RPs: alternative splicing and circular RNAs	45
INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice	45
Corrigendum to: VEGF-B hypertrophy predisposes to transition from diastolic to systolic heart failure in hypertensive rats	43
Specific and common molecular alterations in knock outs of 3 desmosomal genes in HL1 cell model of Arrhythmogenic Cardiomyophathy	42
Hypoxic preconditioning effects change in hypertrophied or insulin resistant rat hearts	42
ProANP31-67 ameliorates adverse cardiac remodeling and improves systolic and diastolic functions in a preclinical model of cardiorenal syndrome	41
Induction of CD73 prevents death after emergency open aortic surgery	41
Increased oxidative stress alters coronary microvascular tone in exercising swine with multiple comorbidities	39
The role of an alpha-selective phosphoinositide-3 kinase inhibitor in vascular inflammation	39
Myostatin deletion reverses myosteatosis and improves angiogenesis in obese mice	39
The ARVC causing TMEM43-p.S358L mutation has impact on the lipid metabolism	38
Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk	38
Identification of cardioprotective miRNAs (protectomiRs) in a porcine model of acute myocardial infarction and cardioprotection by ischemic conditioning	38
Relevance of necroptosis in the hearts subjected to acute versus chronic ischemia/reperfusion injury	37
Cardiomyocyte fusion as a new mechanism contributing to pathological cardiac hypertrophy	37
Modelling and in silico simulation of human induced pluripotent stem cell derived cardiomyocyte electro-mechanical properties	36
Is lumican responsible for the low angiogenetic potential of the adult mammalian heart?	36
Inhibition of novel lipoprotein(a) receptor major facilitator superfamily domain containing 5 (MFSD5) reduces development of aortic valve calcification	36
Proteomics to assess myocardial remodelling in human heart failure and explore the effect of medications and comorbidities	36

Diurnal Variation in thrombolytic status in patients presenting with STEMI	36
Micromanaging atherosclerosis: myeloid cell-specific microRNA-26b attenuates atherosclerosis development	35
B cell depletion skews cd4+ t cell towards a pro-inflammatory phenotype in aged atherosclerotic mice	35
Cardioprotection by limb remote ischemic preconditioning in rats: discrepancy between meta-analysis and a three-center in vivo study	35
Myocardial tissue slices for modeling of the human PLN p.Arg14del associated cardiomyopathy	35
Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets	35
The development of systolic heart failure in case of pressure overload-induced left ventricular myocardial hypertrophy is associated with a unique microRNA expression profile in a rat model	35
Buccal mucosa cells as a potential diagnostic tool to study onset and progression of arrhythmogenic cardiomyopathy	35
Calcium, contraction, and hemodynamic alterations induced by arrhythmogenic drugs in the zebrafish larvae	34
MiR-6821-5p and coronary calcification in familial hypercholesterolemia patients with subclinical atherosclerosis	34
Telomerase and myocardin co-expressing mesenchymal cells increase survival and induce cardiac and vascular markers in cardiac stromal cells undergoing simulated ischemia/reperfusion	34
The role of tachycardia and beta-adrenergic stimulation in inducing early cardiac remodelling	34
Blockers of Hyperpolarization-activated Cyclic Nucleotide-gated channels exhibit antimuscarinic properties in human atrial cardiomyocytes	33
Developing regenerative therapies targeting cardiomyocytes using organotypic slice culture from human adult ventricular myocardium	33
Propafenone as potential AgoKir: exploration of long-term effects and mechanisms of propafenone on Kir2.1 channel	33
Autopsy and genetic characterization of juvenile sudden cardiac arrest and death: the ToRSADE experience	33
Epigenetic and phenotypic characterization of iPSCs-derived smooth muscle cells: towards a cellular model for complex arterial diseases	33
Beneficial impact of pork dry-cured ham consumption on blood pressure and cardiometabolic markers in individuals with high cardiovascular risk	33
Clinical Case 18—Management of patient with cancer and confirmed systemic thrombosis and rectal bleeding	32
Exogenous Growth Differentiation Factor 15 (GDF15) exerts direct cardioprotective properties towards myocardial ischemia reperfusion injury	32
SK channels contribution to ventricular electrophysiology in heart failure patients	32
Oral Presentation No. 107 Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orth	32
Clinical Case 08—A challenging clinical case: acute limb ischemia as a presentation of a left ventricular thrombus in a patient with heart failure with reduced ejection fraction	32
Investigating the cardiotoxicity of particulate matter air pollution using a mouse model	32
Poster No. 118 TheIL6rs1800795polymorphism is associated with ascending thoracic aortic dilatation in bicuspid aortic valve patients	31
Oral Presentation No. 75 Impact of thoracic aortic calcification measured by computed tomography in clinical outcomes in patients undergoing cardiac surgery	31
Oral Presentation No. 46 The effect of covid-19 vaccine on the endothelial function	31
Oral Presentation No. 81 A STEMI case with sub-occlusive lesion and high thrombotic burden – discussing a tailored approach	31
Poster No. 113 Case report: the challenges in diagnosing congenital double-chambered left ventricle in adults	31
Oral Presentation No. 082 Pre-treatment with Dual Antiplatelet Therapy in NSTE-ACS: not always, not ever	31
Oral Presentation No. 093 Assessing different noncoding RNAs as markers of platelet reactivity	31
Clinical Case 03—Coronary subclavian steal syndrome: an unusual cause of acute myocardial infarction	31
Oral Presentation No. 69 Chronotropic incompetence: still a suitable indicator?	30
Oral Presentation No. 019 Bi-directional cross talk between coagulation, fibrinolysis and inflammatory pathways in patients with ST-segment elevation myocardial infarction	30
Oral Presentation No. 079 Quality of life in patients after pulmonary embolism. Correlation with echocardiographic and biochemical parameters	30
Clinical Case 13—An unusual culprit: challenging diagnosis, easy solution	30
Proteomic probing for markers and mechanisms in heart failure	29
Poster No. 106 Can we optimize d-dimer cut off value to predict pulmonary embolism in covid-19 patients?	29
Poster No. 026 Prognostic value of cardiac biomarkers in acute pulmonary embolism: can it add something?	29
Corrigendum to: CHARGE syndrome-associated CHD7 acts at ISL1-regulated enhancers to modulate second heart field gene expression	28
CD69 expression on Treg cells prevents chronic heart damage after myocardial infarction	28
Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation	28
The role of the Hippo pathway in autophagy in the heart	28
Corrigendum to: PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1	28
A novel approach to modelling acute cardiac decompensation in rats	28
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction	28
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size	28
Dysregulation of the endomembrane homeostasis triggers vascular smooth muscle cell phenotype switching	28
Erratum to: Thrombin-activated interleukin-1α drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production	28
LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation	28
Circular RNAs increase during vascular cell differentiation and are biomarkers for vascular disease	28
SETD7 methyltransferase is a key druggable target for effective cardioprotection from myocardial ischaemic injury	27
Genetics of atrial fibrillation—practical applications for clinical management: if not now, when and how?	27
Smooth muscle cell oligoclonality in vascular disease: same origin, different destinies	27
The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload	27
Utilizing biomarkers in atrial fibrillation: the pros and cons	27
A mitochondrial long-chain fatty acid oxidation defect leads to transfer RNA uncharging and activation of the integrated stress response in the mouse heart	27
Retinal microvascular function: a tractable biomarker of cardiovascular risk?	27
Pathophysiology and pharmacology of G protein-coupled receptors in the heart	27
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart	27
Accelerating developments in heart failure	27
A machine learning model identifies a functional connectome signature that predicts blood pressure levels: imaging insights from a large population of 35 882 patients	26
Corrigendum to: Cardiac cellularity is dependent upon biological sex and is regulated by gonadal hormones	26
Preferential uptake of SARS-CoV-2 by pericytes potentiates vascular damage and permeability in an organoid model of the microvasculature	26
Multimodality imaging and transcriptomics to phenotype mitral valve dystrophy in a unique knock-in Filamin-A rat model	26
Is hypothermia more neuroprotective than avoiding fever after cardiac arrest?	26
Trimethylamine N-oxide induces osteogenic responses in human aortic valve interstitial cells in vitro and aggravates aortic valve lesions in mice	26
Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure	26
TNF-α protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells	26
Epicardium-derived extracellular vesicles: a promising avenue for cardiac regeneration	26
Abdominal aortic aneurysms and platelets: infiltration, inflammation, and elastin disintegration	25
Cardiovascular consequences of viral infections: from COVID to other viral diseases	25
Therapeutic targeting of cell transition: ready for clinical prime-time?	25
A transposable element into the human long noncoding RNA CARMEN is a switch for cardiac precursor cell specification	25
Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics	25
At the forefront of basic and translational Cardiovascular Research for 55 years and counting	25
A new year’s resolution to resolve atrial fibrillation: Resolvin D1 emerges as a powerful target against post-MI atrial remodelling	24
Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes	24
Marginal zone B cells produce ‘natural’ atheroprotective IgM antibodies in a T cell–dependent manner	24
Ncf1 knockout in smooth muscle cells exacerbates angiotensin II–induced aortic aneurysm and dissection by activating the STING pathway	24

Donor circadian clock influences the long-term survival of heart transplantation by immunoregulation	24
Cyclophilin A is a ligand for RAGE in thrombo-inflammation	24
Matrix metalloproteinase-3 joins a growing list of proteases that regulate vascular calcification	24
Ryanodine receptor 2 (RYR2) dysfunction activates the unfolded protein response and perturbs cardiomyocyte maturation	23
SR-Mitochondria Crosstalk Shapes Ca Signalling to Impact Pathophenotype in Disease Models Marked by Dysregulated Intracellular Ca Release	23
Scientists on the Spot: Re-awakening the heart’s regenerative capacity	23
Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling	23
Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation	23
FAK in the nucleus prevents VSMC proliferation by promoting p27 and p21 expression via Skp2 degradation	23
From translation to integration: how to approach the complexity of atrial fibrillation mechanisms	23
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation	23
Zebrafish arterial valve development occurs through direct differentiation of second heart field progenitors	23
Spatiotemporal EP4–fibulin-1 expression is associated with vascular intimal hyperplasia	23
From novel discovery tools and biomarkers to precision medicine—basic cardiovascular science highlights of 2021/22	22
Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled tr	22
The healing myocardium mobilizes a distinct B-cell subset through a CXCL13-CXCR5-dependent mechanism	22
VE-PTP inhibition: a novel therapeutic target for hypertension in diabetic patients	22
Cardiac xenotransplantation: from concept to clinic	22
Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner	22
The dual effects of miR-222 in cardiac hypertrophy: bridging pathological and physiological paradigms	22
Scientist on the Spot: Exploring the cause and cure for pulmonary arterial hypertension	22
Epitranscriptomic regulation of cardiac fibrosis via YTHDF1-dependent PIEZO2 mRNA m6A modification	21
Disrupting circadian control of peripheral myogenic reactivity mitigates cardiac injury following myocardial infarction	21
Genetic inhibition of nuclear factor of activated T-cell c2 prevents atrial fibrillation in CREM transgenic mice	21
Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms	21
Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction	21
Finding the culprit for the failure of the immune clock as time goes by	21
Large-scale digital population screening for atrial fibrillation: swinging around the uncertainties	21
Alternative polyadenylation regulation in cardiac development and cardiovascular disease	21
Sudden unexpected death in epilepsy: respiratory vs. cardiac contributions	21
Integration of multiple imaging platforms to uncover cardiovascular defects in adult zebrafish	21
REPRIEVE and CANTOS trials: lessons learned towards eliminating cardiovascular disease in human immunodeficiency virus by combined targeting of LDL and inflammation	20
Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis	20
Extracellular histones are a target in myocardial ischaemia–reperfusion injury	19
Adapting treatments for adaptive immunity in ischaemic heart disease	19
Embryonic alcohol exposure in zebrafish predisposes adults to cardiomyopathy and diastolic dysfunction	19
Inflammation and heart failure: are we facing a ‘hedgehog’s dilemma’?	19
Rapid neutrophil mobilization by VCAM-1+ endothelial cell-derived extracellular vesicles	19
Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer?	19
The backstage of the Russian–Ukrainian war: refugees in urgent need of cardiovascular management	19
The association between kidney function, cognitive function, and structural brain abnormalities in community-dwelling individuals aged 50+ is mediated by age and biomarkers of cardiovascular disease	19
SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS-NO/ROS imbalance	19
Correction to: Role of PDE10A in vascular smooth muscle cell hyperplasia and pathological vascular remodelling	19
Circulating dimethylguanidino valeric acid, dietary factors, and risk of coronary heart disease	19
Lower levels of small HDL particles associated with increased infectious disease morbidity and mortality: a population-based cohort study of 30 195 individuals	19
Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model	19
C–C Motif chemokine receptor-2 blockade ameliorates pulmonary hypertension in rats and synergizes with a pulmonary vasodilator	19
Leaders in cardiovascular research: Eugene Braunwald	18
An antiplatelet response gene expression signature is associated with bleeding	18
Loss of myeloid Bmal1 exacerbates hypertensive vascular remodelling through interaction with STAT6 in mice	18
Annexin A1: a promising target for preventing aortic dissections	18
Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension	18
Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells	18
The post-pandemic legacy: the breakthrough of digital health and telemedicine	18
Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy	18
SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?	17
Response to the clinical commentary ‘Telemedical monitoring by an implanted loop recorder: gateway to personalized medicine? Results of the SMART-MI study’	17
MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling	17
Activating P2Y1 receptors improves function in arteries with repressed autophagy	17
Should we resurrect acetazolamide as a diuretic for congestion due to heart failure?	17
Corrigendum to: Clinical Case 29—The role of transthoracic echocardiography on patients presenting with shock of unknown etiology	17
Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol	17
Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcircul	17
Gene therapy with phosphodiesterases 2A and 4B ameliorates heart failure and arrhythmias by improving subcellular cAMP compartmentation	17
Nicotine exacerbates endothelial dysfunction and drives atherosclerosis via extracellular vesicle-miRNA	17
The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies	17
Single-cell transcriptomic analyses of cardiac immune cells reveal that Rel-driven CD72-positive macrophages induce cardiomyocyte injury	17
Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device	17
SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy	17
Physiological and pathological ventricular hypertrophy: a role for cavin-2 mediated Akt regulation	17
PINK1-mediated mitophagy attenuates pathological cardiac hypertrophy by suppressing the mtDNA release-activated cGAS-STING pathway	16
Anaplerotic filling in heart failure: a review of mechanism and potential therapeutics	16
Novel ex-vivo calcification model for human aortic valves reveals patient-specific effect of compound	16
Mapping the developing human cardiac endothelium at single-cell resolution identifies MECOM as a regulator of arteriovenous gene expression	16
Single-cell RNA sequencing identifies interferon-inducible monocytes/macrophages as a cellular target for mitigating the progression of abdominal aortic aneurysm and rupture risk	16
Down-regulation of AMPK/PPARδ signalling promotes endoplasmic reticulum stress-induced endothelial dysfunction in adult rat offspring exposed to maternal diabetes	16
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects	15
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working	15
Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions	15
A paradigm shift in cardiovascular research – new method isolates intestinal interstitial fluid to understand gut microbiome and host cross talk	15
An emerging epigenetic path towards cardiomyocyte maturation	15
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity	15
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes	15
Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage	15
Aircraft noise exposure induces pro-inflammatory vascular conditioning and amplifies vascular dysfunction and impairment of cardiac function after myocardial infarction	15
Doxorubicin-induced cardiovascular toxicity: a longitudinal evaluation of functional and molecular markers	15
Frequent premature atrial contractions as a signalling marker of atrial cardiomyopathy, incident atrial fibrillation, and stroke	15
Impairment of mitophagy and autophagy accompanies calcific aortic valve stenosis favouring cell death and the severity of disease	15
The role of cellular senescence in profibrillatory atrial remodelling associated with cardiac pathology	14
Senescence mechanisms and targets in the heart	14
Cardiometabolic disease: linking pathogenic mechanisms to therapeutic opportunities	14
Sex-biased TGFβ signalling in pulmonary arterial hypertension	14
Double-stranded DNA enhances platelet activation, thrombosis, and myocardial injury via cyclic GMP-AMP synthase	14
Focus on the road to modelling cardiomyopathy in muscular dystrophy	14
Integrin beta-like 1 mediates fibroblast–cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy	14